Tuberculosis

Investigation of human immune signatures of latent MTB infection, active disease and BCG vaccination. (NIH/NIAID, U19 AI118626)

Proteome-wide characterization of T cell epitopes from Mycobacterium tuberculosis in vaccination and active infection. (NIH/NIAID, 75N93019C00067)

Goal: To define MTB-derived T cell epitopes associated with vaccination and active TB infection, and submit them to the IEDB.

About La Jolla Institute

The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease. Visit lji.org for more information.

LATEST NEWS

Share this Article:

  • Institute News

Pioneering LJI scientists Erica Ollmann Saphire and Mitchell Kronenberg elected to the American Academy of Arts and Sciences

Saphire and Kronenberg have made major immunology breakthroughs. Now they will receive one of the nation's highest honors.
Read More
  • Research News

We’re taking a closer look at immune ‘memory’

Vaccines teach the body to fight disease. We still have a lot to learn about how long that immune "memory" lasts.
Read More
A colorized microscopy image showing influenza virus in orange, with a teal background. The virus looks like roundish blobs.
  • Blog

Answering big questions about the new flu and SARS-CoV-2 viral variants

An immunology perspective on the influenza "subclade K" variant and the SARS-CoV-2 "Cicada" variant
Read More